Clinical Trial Update: Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether adding back estrogen during the hormone-free interval reduces menstrual migraines in women using continuous ora…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Continuous oral contraceptive
• Estrogen add-back therapy

Snippet

Sponsor: Scott and White Hospital & Clinic | Conditions: Menstrual Migraines, Menstrual Bleeding | Phase 4 | Status: UNKNOWN